Health

Artificial intelligence diagnostic tools are transforming patient care worldwide, with hospitals reporting faster, more accurate disease detection across multiple specialties.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with new approvals and research expanding their medical applications.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment, with new data confirming cardiovascular and kidney benefits.

GLP-1 receptor agonists like semaglutide and tirzepatide continue to transform obesity treatment, cardiovascular care, and healthcare systems worldwide.

A closer look at the ingredients, additives, and ultra-processing in a bag of Cheetos, and what the science actually says about frequent consumption of foods like this.

GLP-1 receptor agonists like semaglutide continue transforming obesity treatment worldwide, with expanded access, new indications, and mounting research reshaping healthcare systems.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with expanding approvals and growing evidence of broader health benefits.

Semaglutide and tirzepatide continue to transform obesity treatment worldwide, with new research expanding their benefits beyond weight loss.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with expanding approvals and growing access debates.

GLP-1 receptor agonists like semaglutide and tirzepatide continue to dominate health headlines as new data confirms cardiovascular and metabolic benefits beyond weight loss.

Hantavirus broke into Google's global top searches in 2026 after a cruise-ship outbreak. Here are the facts from the CDC and WHO.

Medications like semaglutide and tirzepatide continue to transform obesity treatment worldwide, with expanding approvals and growing evidence of cardiovascular benefits.

GLP-1 weight loss drugs like Ozempic and Wegovy have transformed 30 million lives, but rising concerns about side effects and cost demand attention.

Behind the colorful screens and millions of views lies a growing concern: children becoming addicted to content built around adults playing with toys. As entertainment turns into profit, we must ask whether we are nurturing creativity—or encouraging unhealthy screen dependency. The future of our children deserves serious attention.

A Harvard study finds AI outperforms experienced physicians at diagnosing patients using electronic health records.